Department of Oral Medicine and Radiology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai- 600077, Tamil Nadu, India.
Department of Oral and Maxillofacial Surgery, Vyas Dental College and Hospital, Jodhpur, Rajasthan, India.
Asian Pac J Cancer Prev. 2021 Dec 1;22(12):3941-3947. doi: 10.31557/APJCP.2021.22.12.3941.
To determine the therapeutic efficacy of Kali haldi in the management of Oral submucous Fibrosis (OSMF) v/s steroid therapy.
A clinical prospective study was conducted on 42 patients of oral submucous fibrosis were equally divided into 2 groups. Group A patients were treated with a mixture of powdered Kali Haldi and aloe vera gel in equal ratio 3 times a day for 3 months. Group B patients were treated with intralesional injection of hydrocortisone and hyaluronidase for 6 weeks with oral antioxidant supplements for 3 months. Burning sensation, cheek flexibility, mouth opening, and tongue protrusion were evaluated before, during, and after treatment at an interval of 15 days, 1 month, 2, month and 3 months.
Statistically significant results were obtained at the end of 3 months duration for both the groups (P < 0.001). The Symptomatic correction was more evident in the case of Group A patients than Group B. Response of the ayurvedic regimen was potentially better as compared to the regular steroid therapy.
The study concludes that Combination therapy works wonders in the case of OSMF in stages I, II, III and can be a good option, comparatively safe and with negligible side effects, but potent and equally effective management of oral submucous fibrosis. Henceforth, it will be better to do such kinds of studies on a vast scale including larger samples and longer duration to check the efficacy and durability of this ancient ayurvedic regimen.
比较 Kali haldi 疗法与皮质类固醇治疗口腔黏膜下纤维化(OSMF)的疗效。
对 42 例口腔黏膜下纤维化患者进行前瞻性临床研究,将患者等分为两组。A 组患者用 Kali Haldi 与芦荟凝胶的混合物治疗,比例为 1:1,每天 3 次,持续 3 个月。B 组患者接受皮质类固醇(曲安奈德)和透明质酸酶的局部注射治疗,同时口服抗氧化补充剂 3 个月。在治疗前、治疗期间和治疗结束后 15 天、1 个月、2 个月和 3 个月时评估患者的烧灼感、颊部灵活性、张口度和伸舌度。
两组患者在 3 个月治疗结束时均获得统计学意义上的显著结果(P<0.001)。与 B 组相比,A 组患者的症状改善更为明显。与常规皮质类固醇治疗相比,阿育吠陀疗法的疗效可能更好。
本研究表明,对于 I、II、III 期 OSMF,联合治疗效果显著,是一种相对安全、副作用小、但疗效强且同样有效的口腔黏膜下纤维化治疗方法。因此,最好在更大规模上进行此类研究,纳入更大的样本量和更长的随访时间,以进一步验证这种古老的阿育吠陀疗法的疗效和耐久性。